Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 79068-31-8 | MDL No. : | MFCD11975599 |
Formula : | C6H7NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WDPQPKMCONIREA-UHFFFAOYSA-N |
M.W : | 141.13 | Pubchem ID : | 54711834 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 34.1 |
TPSA : | 62.32 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.39 cm/s |
Log Po/w (iLOGP) : | 1.35 |
Log Po/w (XLOGP3) : | 1.09 |
Log Po/w (WLOGP) : | 0.51 |
Log Po/w (MLOGP) : | -0.56 |
Log Po/w (SILICOS-IT) : | 0.77 |
Consensus Log Po/w : | 0.63 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.64 |
Solubility : | 3.24 mg/ml ; 0.0229 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.99 |
Solubility : | 1.44 mg/ml ; 0.0102 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.08 |
Solubility : | 11.7 mg/ml ; 0.0826 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 113602-62-3 ]
Methyl 3-hydroxy-1-methyl-1H-pyrrole-2-carboxylate
Similarity: 0.95
[ 24985-85-1 ]
Ethyl 5-hydroxyindole-2-carboxylate
Similarity: 0.70
[ 1352925-63-3 ]
Ethyl 4,6-dihydroxypyridazine-3-carboxylate
Similarity: 0.66
[ 40047-23-2 ]
6-Hydroxyindole-2-carboxylic acid
Similarity: 0.65
[ 84639-84-9 ]
7-Hydroxyindole-2-carboxylic acid
Similarity: 0.65
[ 113602-62-3 ]
Methyl 3-hydroxy-1-methyl-1H-pyrrole-2-carboxylate
Similarity: 0.95
[ 1193-62-0 ]
Methyl 1H-pyrrole-2-carboxylate
Similarity: 0.81
[ 1197-13-3 ]
Methyl 5-formyl-1H-pyrrole-2-carboxylate
Similarity: 0.80
[ 1194-97-4 ]
Methyl 5-methyl-1H-pyrrole-2-carboxylate
Similarity: 0.80
[ 2199-43-1 ]
Ethyl 1H-pyrrole-2-carboxylate
Similarity: 0.79
[ 113602-62-3 ]
Methyl 3-hydroxy-1-methyl-1H-pyrrole-2-carboxylate
Similarity: 0.95
[ 1193-62-0 ]
Methyl 1H-pyrrole-2-carboxylate
Similarity: 0.81
[ 1197-13-3 ]
Methyl 5-formyl-1H-pyrrole-2-carboxylate
Similarity: 0.80
[ 1194-97-4 ]
Methyl 5-methyl-1H-pyrrole-2-carboxylate
Similarity: 0.80
[ 2199-43-1 ]
Ethyl 1H-pyrrole-2-carboxylate
Similarity: 0.79